Bladder Cancer Screening Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorUniversity of Texas Southwestern Medical Center
About this trial
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
Eligibility criteria
Qualifiers
Age ≥ 50
Smoking: ≥15 pack-year smoking history
Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
Disqualifiers
Prior history of bladder, kidney, or prostate cancer
Prior evaluation of micro or gross hematuria within the last 2 years
Do not provide informed consent
Trial design
Treatments tested in this trial
- Urinalysis
Treatment groups
1,000 Participants
are divided into 2 treatment groupsLocations
1University of Texas Southwestern Medical Center75390, DallasTexas, United States
Sponsors and collaborators
University of Texas Southwestern Medical Center
Lead sponsor
Wilson Charitable Foundation Trust
Collaborator
Pacific Edge Limited
Collaborator
Source ClinicalTrials.gov